263 related articles for article (PubMed ID: 17358026)
1. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.
Walker DM; Malarkey DE; Seilkop SK; Ruecker FA; Funk KA; Wolfe MJ; Treanor CP; Foley JF; Hahn FF; Hardisty JF; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):283-98. PubMed ID: 17358026
[TBL] [Abstract][Full Text] [Related]
2. Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.
Diwan BA; Riggs CW; Logsdon D; Haines DC; Olivero OA; Rice JM; Yuspa SH; Poirier MC; Anderson LM
Toxicol Appl Pharmacol; 1999 Nov; 161(1):82-99. PubMed ID: 10558926
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.
Hong HH; Dunnick J; Herbert R; Devereux TR; Kim Y; Sills RC
Environ Mol Mutagen; 2007; 48(3-4):299-306. PubMed ID: 16395694
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53-haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC.
Dobrovolsky VN; Shaddock JG; Mittelstaedt RA; Bishop ME; Lewis SM; Lee FW; Aidoo A; Leakey JE; Dunnick JK; Heflich RH
Environ Mol Mutagen; 2007; 48(3-4):270-82. PubMed ID: 17358030
[TBL] [Abstract][Full Text] [Related]
6. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
[TBL] [Abstract][Full Text] [Related]
7. Oxidative DNA damage in fetal tissues after transplacental exposure to 3'-azido-3'-deoxythymidine (AZT).
Bialkowska A; Bialkowski K; Gerschenson M; Diwan BA; Jones AB; Olivero OA; Poirier MC; Anderson LM; Kasprzak KS; Sipowicz MA
Carcinogenesis; 2000 May; 21(5):1059-62. PubMed ID: 10783333
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and carcinogenesis studies of mixtures of 3'-azido-3'-deoxythymidine (AZT), lamivudine (3TC), nevirapine (NVP), and nelfinavir mesylate (NFV) (Cas Nos. 30516-87-1, 134678-17-4, 129618-40-2, 159989-65-8) in B6C3F1 Mice (transplacental exposure studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Jan; (569):1-212. PubMed ID: 23385634
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother-child pairs to AZT or AZT-3TC.
Escobar PA; Olivero OA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Day RD; Day BW; Meng Q; O'Neill JP; Walker DM; Poirier MC; Walker VE; Bigbee WL
Environ Mol Mutagen; 2007; 48(3-4):330-43. PubMed ID: 17358027
[TBL] [Abstract][Full Text] [Related]
10. Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD-1 mice to single agents or drug combinations.
Torres SM; Walker DM; Carter MM; Cook DL; McCash CL; Cordova EM; Olivero OA; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):224-38. PubMed ID: 17358033
[TBL] [Abstract][Full Text] [Related]
11. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment.
Witt KL; Tice RR; Wolfe GW; Bishop JB
Environ Mol Mutagen; 2004; 44(4):321-8. PubMed ID: 15476197
[TBL] [Abstract][Full Text] [Related]
12. Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.
Zhang Z; Diwan BA; Anderson LM; Logsdon D; Olivero OA; Haines DC; Rice JM; Yuspa SH; Poirier MC
Mol Carcinog; 1998 Sep; 23(1):45-51. PubMed ID: 9766437
[TBL] [Abstract][Full Text] [Related]
13. Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs.
Poirier MC; Olivero OA; Walker DM; Walker VE
Toxicol Appl Pharmacol; 2004 Sep; 199(2):151-61. PubMed ID: 15313587
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors.
Olivero OA
Environ Mol Mutagen; 2007; 48(3-4):215-23. PubMed ID: 16395695
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
16. Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs.
Meng Q; Olivero OA; Fasco MJ; Bellisario R; Kaminsky L; Pass KA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Bigbee WL; O'Neill JP; Walker DM; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):307-21. PubMed ID: 17358024
[TBL] [Abstract][Full Text] [Related]
17. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavage.
Bishop JB; Witt KL; Tice RR; Wolfe GW
Environ Mol Mutagen; 2004; 43(1):3-9. PubMed ID: 14743340
[TBL] [Abstract][Full Text] [Related]
18. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
19. Does perinatal antiretroviral therapy create an iatrogenic cancer risk?
Wogan GN
Environ Mol Mutagen; 2007; 48(3-4):210-4. PubMed ID: 17358028
[TBL] [Abstract][Full Text] [Related]
20. 3'-azido-3'-deoxythymidine induces deletions in L5178Y mouse lymphoma cells.
Wang J; Chen T; Honma M; Chen L; Moore MM
Environ Mol Mutagen; 2007; 48(3-4):248-57. PubMed ID: 17358034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
